F-1/A: EMPRO Group Inc. Files for IPO to Fuel Expansion in Beauty and Healthcare Markets

EMPRO Group Inc., a Cayman Islands-based company with Malaysian operations, has filed an F-1/A registration statement for an initial public offering (IPO) to support its growth strategies in the beauty and healthcare sectors.

Summary

• EMPRO Group Inc., operating through its Malaysian subsidiary EMP Solution, has filed for an IPO.
• The company intends to list its Ordinary Shares on the Nasdaq Capital Market under the symbol EMPG.
• The IPO aims to raise capital for working capital, market penetration, operating expenses, and transaction expenses.
• EMPRO Group's business spans nearly two decades, originating in the beauty industry and expanding into healthcare.
• The company distributes healthcare and beauty products throughout the ASEAN region and Europe, with flagship products including triangular eyebrow pencils and medical face masks.
• For the fiscal year ended December 31, 2023, total revenue was approximately $3.70 million, with a net loss of approximately $0.32 million.
• For the six months ended June 30, 2024, total revenue was approximately $1.70 million, with a net loss of approximately $0.28 million.
• The company's revenue decreased in 2023 due to reduced demand for medical masks and COVID-19 test kits, but it is focusing on expanding its cosmetics and skincare business.
• The initial public offering price is expected to be in the range of $[] to $[] per share.
• Prof. Dr. Yeoh Chee Wei, the founder, is expected to beneficially own approximately []% of the company's outstanding Ordinary Shares after the IPO, making it a controlled company.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While the company is pursuing growth opportunities through an IPO and has a history of success, it also faces challenges such as declining revenue and net losses. The company's future performance is uncertain, and there are several risks associated with investing in its Ordinary Shares.

Positives

• The company has a rich brand history spanning nearly two decades.
• EMPRO has a track record of delivering safe, efficacious, and innovative beauty and healthcare products.
• The company has received numerous accolades and awards for its contributions to the beauty and healthcare industry.
• EMPRO's marketing strategy is adaptable, designed to evolve in response to local market dynamics.
• The company anticipates revenue diversification following the introduction of new products in its beauty segment.
• EMPRO has developed strong relationships with partners, regulators, and government agencies.
• The company boasts a robust and experienced management team.

Negatives

• The company experienced a net loss of approximately $0.32 million for the fiscal year ended December 31, 2023.
• The company experienced a net loss of approximately $0.28 million for the six months ended June 30, 2024.
• The company's total revenue decreased considerably during the 2023 fiscal year due to a marked reduction in COVID-19 cases.

Risks

• The company operates in a dynamic healthcare and beauty industry and has a limited operating history.
• The healthcare industry and the beauty industry are highly competitive.
• The company's success is dependent on the continued popularity of its healthcare and beauty products and its ability to anticipate and respond to changes in the healthcare and beauty industry trends and consumer preferences and behavior in a timely manner.
• The company's total revenue, and the revenue generated by its healthcare business segment, decreased considerably during the 2023 fiscal year due to a marked reduction in COVID-19 cases.
• The company's new product introductions may not be as successful as it anticipates, which could have a material adverse effect on its business, prospects, financial condition, and results of operations.
• The company's business depends, in part, on the quality, effectiveness and safety of its healthcare and beauty products.
• The company may not be able to successfully implement its growth strategy.
• The company may be unable to manage its growth effectively or efficiently.
• The company may not be able to maintain profitability in the future.

Future Outlook

The company intends to develop its business and strengthen brand loyalty by expanding its product offerings, expanding into new markets and territories within ASEAN and Europe, and investing in new technologies.

Industry Context

The beauty market is experiencing significant growth both globally and in the Asia-Pacific region (APAC), excluding China. Globally, the industry is projected to generate retail sales of $460 billion in 2023, with expectations to reach $580 billion by 2027, demonstrating a compound annual growth rate (CAGR) of approximately 6%. In the APAC region, excluding China, the market is notably robust, expected to achieve retail sales of $118 billion in 2023, accounting for around 26% of the global market. This market is anticipated to outpace the global growth rate, with a CAGR of approximately 7%, reaching $151 billion by 2027.

Comparison to Industry Standards

• The company competes with both established multinational and domestic brands within the healthcare and beauty industries, as well as small targeted niche brands.
• With respect to its cosmetic products, and in particular its eyebrow pencils, the company believes that its primary competitors are Shu Uemura (a luxury Japanese brand that is currently controlled by the LOral Group), and the Bobbi Brown brand owned by The Este Lauder Companies.
• With respect to its SpaceLift skincare product, the company believes that its primary competitors are (A) Clarins, (B) SK-II, (C) Kiehls, (D) Hada Labo, and (E) Eucerin.
• With respect to its medical face mask products, the company believes that its primary competitors are the Malaysian brands Medicos and Neutrovis.

Related Party Transactions

• EMP Solution has an Exclusive Sole Distribution Agreement with Jingga Anggun Sdn Bhd, where the sole director is the son of Prof. Yeoh and the Chief Operating Officer is Chin Gan Keat.
• EMP Solution has an arrangement with Mosfac Sdn Bhd, where Prof. Yeoh is a 50% shareholder and a director.
• EMP Solution has outstanding receivables from Mimo Motor Sdn Bhd, where Prof. Yeoh is the sole shareholder and a director.
• EMP Solution has outstanding receivables from Emptech Upcycle Sdn Bhd, where Prof. Yeoh is the sole shareholder and a director.

Stakeholder Impact

• Shareholders will be affected by the dilution of their ownership interest due to the issuance of new shares in the IPO.
• Employees may benefit from the company's growth and expansion plans, which could lead to new job opportunities.
• Customers may benefit from the company's commitment to providing safe, efficacious, and innovative beauty and healthcare products.
• Suppliers and creditors may be affected by the company's financial performance and its ability to meet its obligations.

Next Steps

• The company intends to use the proceeds from this offering for working capital, market penetration and development, operating expenses and transaction expenses.
• The company plans to expand its product offerings and develop new products.
• The company plans to expand into new markets and territories within ASEAN and Europe.
• The company plans to invest in new technologies.

Key Dates

Keywords

IPO, beauty, healthcare, EMPRO Group, EM Solution, cosmetics, skincare, medical face masks, ASEAN, Nasdaq